Introduction
Concern about the potential health hazards resulting from environmental pollution by the chlorinated dibenzo-p-dioxins and dibenzofurans arises from our recognition of the extraordinary potency of these compounds as toxins and teratogens and their inadvertant dispersion in the environment as contaminants of chlorinated phenolic products. Questions concerning the extent of environment contamination and those concerning the mechanism of toxicity produced by these compounds are at present unanswerable. Several papers in this symposium have presented the historical background which led to our current understanding and concern about this problem: (1) the "chick-edema" outbreaks caused by "toxic fats" in poultry feed and the eventual isolation and identification of a hexachlorinated dibenzo-p-dioxin; (2) the occurrence of acne among workers in several 2,4,5-T factories and recognition of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) as the etiologic agent; (3) the NCIcommissioned study on the potential teratogenicity, carcinogenicity and mutagenicity of 2,4,5-T; (4) Orange as a defoliant in Viet Nam and Cambodia. The starting point of our studies was a report by Bleiberg and colleagues (1) that of 29 workers in a 2,4,5-T factory, all of whom had industrially acquired acne, 11 had porphyrinuria and several had overt clinical porphyria cutanea tarda. TCDD has been shown to be the causative agent of the acne; however, the cause of the porphyria was uncertain. Porphyria cutanea tarda is an acquired defect of hepatic porphyrin metabolism characterized by an overproduction of porphyrins by the liver, increased urinary excretion of porphyrins, mechanical fragility and photosensitivity of the skin (blistering in areas exposed to sunlight), hyperpigmentation, and hirusitism. We restudied the factory 5 years later and found no evidence of porphyria in the employees (2) . The fact that this syndrome abated following measures to reduce the formation TCDD and minimize employee exposure to this contaminant, suggested that TCDD might have been the causative agent of the industrial outbreak originally reported by Bleiberg et al. (1) .
Methods and Materials
The halogenated dibenzo-p-dioxins and dibenzofurans and analyses of their purity were generously provided by Dr had two common properties: (1) halogen atoms occupy at least three of the four lateral ring positions (2, 3, 7, and 8) and (2) there is at least one free, nonhalogenated carbon atom. Note that octachlorodibenzo-p-dioxin is inactive. The compounds that were not inducers were tested at 200-400 times the molar concentration of TCDD that produced a significant response.
To the extent that toxicologic data are available (5), all those dioxins which are at low doses lethal, teratogenic, or produce acne, also induce ALA synthetase, and those dioxins which are not potent toxins do not induce ALA synthetase. We have also tested a limited series of dibenzofurans; the unsubstituted compound and 2,8-dichloro and octachloro derivatives all fail to induce, and a mixture of di-tri-and tetrachlorodibenzofurans is potent as an inducer of ALA synthetase. While the data are very limited, it appears the structure-activity relationship is similar in the dibenzofuran series.
As reported elsewhere in this symposium (6), TCDD does not induce ALA synthetase in several laboratory mammals. We have found it to be a poor inducer in the rat. This should not be interpreted to mean that the results obtained in the avian embryo have no relevance to man. For instance, many sex steroids appear to play a role in precipitating acute intermittent prophyria and porphyria cutanea tarda in man; however, while induction of ALA synthetase by these compounds can be shown in the chick embryo, it does not occur in the rat.
There is an empiric relationship observed by numerous investigators that many compounds which induce ALA synthetase also induce microsomal mixed-function oxygenase activity in the liver (also called the "drug metabolizing enzymes"). Two points are of note about this correlation: not all drugs induce both enzyme activities; also, the relationship many have a theoretical basis, in that heme is the prosthetic group of the terminal component of microsomal oxygenase, cytochrome P-450. The high concentration of cytochrome P-450 and rapid turnover relative to all other hepatic hemoproteins, accounts for a large fraction of the total heme synthesized in the control liver. Some investigators have suggested that coordinate induction of ALA synthetase, the rate-limiting step in heme synthesis, and cytochrome P-450 and microsomal oxygenase activity may have a basis in providing the extra heme necessary for forming the new cytochrome P-450. Despite this not very satisfying teleologic explanation, there is a sizable literature reporting the concommitant induction of ALA synthetase and microsomal oxygenase activity.
We next studied the effect of TCDD on microsomal oxygenase. As a measure of this enzyme complex we choose to investigate aryl hydrocarbon hydroxylase activity, because aromatic hydroxylation is induced primarily by aromatic compounds, which in our view chemically resemble TCDD.
As seen in Figure 3 , TCDD produces a doserelated induction of aryl hydrocarbon hydroxylase in chick embryo liver. At the lowest dose tested, 1.55 x 10-12 mole/egg (0.5 ng) there is a nearly twofold increase in enzyme activity, and maximal induction is produced (Fig. 4) . The structureactivity relationship is identical to that seen with the induction of ALA synthetase: (1) the compounds which are potent inducers (induction at 4.7 or 47 x 10-1" mole/egg) have halogen atoms at least three of the four lateral ring positions and (2) they have at least one nonhalogenated ring position. There is one exception, the 1,2,4,6,7,9-hexachlorodioxin, which at high doses (470 x 10-11 mole/egg) produced a modest induction of aryl hydrocarbon hydroxylase. This compound was only 90%o pure by gas-liquid chromatography, and the induction observed at the highest dose could be produced by contamination with as little as 0.1 So (w/w) TCDD or an equipotent dioxin. Clarification must await the availability of a purer preparation of this hexachloro isomer.
There are certain advantages to investigating the induction of hydroxylase activity produced by TCDD in the rat, namely: one can more fully examine the duration of induction, and also the spectral changes in cytochrome P-450 accompanying aryl hydrocarbon hydroxylase induction are more fully documented in the rat. The administration TCDD (moles/kg)
In Figure 6 we have plotted the results of the time course of induction produced by 3-methylcholanthrene (20 mg/kg in corn oil), TCDD (10 jug/kg in p-dioxine) and control rats (receiving either corn oil or pdioxane). Aryl hydrocarbon hydroxylase is induced to the same extent at 1 and 4 days by maximally inducing doses of each drug. However, by 8 days, hydroxylase activity in the 3-methylcholanthrene-treated rats returned to control levels, while induction persisted in the TCDD-treated rats for over 1 month. Accompanying the induction of aryl hydrocarbon hydroxylase by both drugs the following changes were noted: an increase in the total CO-binding microsomal cytochrome (cytochrome P-450 and P-448), a shift in the CO-maximum peak by difference spectroscopy from 450 nm to 448 nm, and a shift in the ratios of the peaks observed with ethyl isocyanide as a ligand by difference spectroscopy. These changes are interpreted to mean both 3-methylcholantrene and TCDD 18 FIGURE 5. Logarithmic dose-response curve for the induction of aryl hydrocarbon hydroxylase in rat liver. Male Sprague-Dawley rats weighing about 80 g were injected intraperitoneally with TCDD dissolved in p-dioxane or p-dioxane alone (0.3 ml/kg), and hepatic aryl hydrocarbon hydroxylase activity was assayed 24 hr later. Each point is the mean ± standard error of five animals. induce the formation of a new type of cytochrome P-450 which contains its heme iron in a high-spin state. We have also found that both TCDD and methylcholanthrene produce induction of aryl hydrocarbon hydroxylase in a number of extrahepatic tissues. In summary, TCDD appears to be similar to 3-methylcholanthrene as an inducer of microsomal oxygenase differing primarily in potency (by four orders of magnitude) and duration of action. The persistent induction following TCDD administration is probably a result of its long biological half-life.
Discussion
The results of our investigation demonstrate TCDD is a potent inducer of ALA synthetase and aryl hydrocarbon hydroxylase in the chick embryo liver. There is a perfect correlation between those dioxins which induce both enzymes and the toxicity lata, to the extent the data are available on bhe various dioxins. The structure-activity relationship reveals that all dioxins which ,re potent inducers have halogens at three )f the four lateral ring positions and at least mne nonhalogenated carbon atom. The sen3itivity of induction of aryl hydrocarbon hydroxylase by TCDD and other toxic dioxins suggests this response might be a very valuable screening bioassay to detect the presence of the toxic dioxins in commercial products or environmental samples. It We propose a similar model for the toxicity of TCDD. The parent compound enters the cell and binds to some induction-receptor site which initiates the events which ultimately lead to the formation of more aryl hydrocarbon hydroxylase activity. TCDD is recognized by a second site in the cell, the enzyme-active center of microsomal oxygenase, and converted to a reactive metabolite, possibly an epoxide. The conversion of TCDD to its reactive metabolite is the rate-limiting step in dioxin metabolism, and this step is increased by the induction of aryl hydrocarbon hydroxylase. Some of these reactive metabolite molecules bind to cellular macromolecules producing some impairment of function which gradually produces cell death.
It is useful to examine this hypothesis; in light of the known facts concerning TCDD toxicity. The large difference in species susceptibility to TCDD might be explained by the differences in the rate of metabolism of TCDD. The multiple organ damage produced by TCDD and variable pattern of histologic damage in different species might be explained by the relative rate of formation and further inactivation of the reactive metabolite in different organs. (3) As pointed out by Gehring (10), there is some evidence, far from unequivocal, that the administration of C14-TCDD results in unextractable radioactivity in rat liver. (4) The teratogenic effect of TCDD may be a result of mutagenesis by intercalation of the parent compound into DNA (11) or by intercalation and covalent binding of the metabolite, analogous to the acridine and aminofluorene compounds (12, 13) . This hypotesis is highly speculative and presented only to encourage further investigation. The major assumptions remain unsupported: (1) TCDD is metabolized, and (2) the metabolite covelently binds to some cellular constituent. The demonstration that both these events do or do not occur must await the synthesis of radioactive TCDD of high specific activity.
